Found 7 matching trials
Comparison of I-124 and I-131 Radiopharmacokinetics in DTC Patients With Thyroid Hormone Withdrawal
NAThis research study is to compare the radiopharmacokinetics of I-124 to the...
Location
Washington Hospital Center
Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers
NAThis is a treatment protocol designed to accompany the ongoing institutiona...
Location
Stanford University School of Medicine
Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy
PHASE2Progressive and metastatic thyroid cancer patients, who no longer respond t...
Location
National University Hospital
A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma
PHASE1This study aims to show that 3-dimensional PET/CT imaging with a new novel ...
Location
University College London Hospital
Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244
NAThe purpose of this study is to find out if the drug AZD6244 can improve th...
Location
Memorial Sloan-Kettering Cancer Center
A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
PHASE1This study will investigate 99mTc-p5+14, an amyloid-reactive synthetic pept...
Location
University of Tennessee Graduate School of Medicine
Comparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH)
NAThis research study is to compare the radiopharmacokinetics of I-124 to the...
Location
Washington Hospital Center